Longwood Founders Fund

Longwood Founders Fund

Longwood Founders Fund

Suggest edits
Follow us
Also headquartered in Boston
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 7

Portfolio

Portfolio Tracker

Add info
$25,000,000 Venture capital (Series B)
FinSMEs

Axial Biotherapeutics Raises $25M in Series B Financing

Axial Biotherapeutics
Axial Biotherapeutics
$30,000,000 Venture capital
FinSMEs

OvaScienceSM and Millendo Therapeutics Merge; New Company Raises $30M

Funding Strategy Science
Millendo Therapeutics
Millendo Therapeutics
Xconomy

At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA

Health
Verastem
Verastem
$14,100,000 Venture capital (Series C)
medicaldevicedaily , vcaonline

BioWorld MedTech

Channe Medsystems, Inc.
Channe Medsystems, Inc.
Xconomy

Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug

Health Science
Verastem
Verastem
Xconomy

Millendo Launches Phase 2b Study of PCOS Drug After Year of Growth

Health Science
Millendo Therapeutics
Millendo Therapeutics
$62,000,000 Venture capital (Series B)
FinSMEs

Millendo Therapeutics Raises $62M in Series B Funding

Health Funding
Millendo Therapeutics
Millendo Therapeutics
Xconomy

Verastem Sinks as Mesothelioma Study Halted For Futility

Health